Riham Bokhtia | Molecular | Editorial Board Member

Editorial Board Member

  Riham Bokhtia
Affiliation Faculty of Pharmacy, Zagazig University
Country Egypt
Scopus ID 57209660751
Documents 13
Citations 152
h-index 6
Subject Area Molecular
Event International Research Chemistry Awards
ORCID 0000-0001-5326-7364

Riham Bokhtia is affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, and has developed a research profile represented in international scholarly indexing systems. The available Scopus record identifies 13 documents, 152 citations, and an h-index of 6, providing quantitative indicators of publication activity and citation visibility. [1]

Abstract

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy, Zagazig University, Egypt. Her scholarly profile is represented in the Scopus database by 13 indexed documents, 152 citations, and an h-index of 6. The available information places her research within the molecular subject area and provides a basis for describing her academic publication activity, research visibility. [1]

Keywords

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, with research interests spanning molecular chemistry. Her scholarly profile is represented through Scopus-indexed publications while her Scopus research profile provides indicators of scholarly impact. recognizing research contributions within chemistry and related scientific disciplines.[2]

Introduction

Academic research profiles provide a structured means of evaluating scholarly activity through publication records, citation patterns, and bibliometric indicators. Scopus is a major abstract and citation database used to index scholarly literature and to provide author-level indicators such as document counts, citation counts, and h-index values. [1]

Research Profile

The available bibliometric information identifies a documented research record associated with a Scopus Author profile. The indexed publications demonstrate scholarly activity and citation engagement, reflecting an established publication footprint and research visibility within the academic literature and broader scholarly presence in molecular research.[4]

Research Contributions

Bokhtia’s research profile is situated at the intersection of molecular science and pharmaceutical research. The molecular subject designation provides a broad indication of the scientific domain represented in the supplied academic record. Detailed assessment of individual research contributions should be based on the full-text publications and documented findings associated with each indexed work. [3]

Publications

For formal academic evaluation, the publication record can be reviewed through the researcher’s Scopus profile and, where available, individual publisher records and DOI registrations. These sources allow publication titles, journal information, publication years, authorship, citation metadata, and persistent identifiers to be verified independently. [4]

Research Impact

The reported 152 citations provide an observable indicator of scholarly use or discussion of the indexed documents, while the h-index of 6 indicates that at least six indexed publications have each received at least s ix citations under the relevant database calculation. Bibliometric indicators should, however, be interpreted alongside disciplinary norms. [2]

Award Suitability

On the supplied evidence, her profile demonstrates established scholarly activity through 13 Scopus-indexed documents, 152 citations, and an h-index of 6.  Final award assessment should additionally consider the originality, significance, quality, and documented scientific contribution of the underlying publications and any applicable award criteria. [3]

Conclusion

Riham Bokhtia’s academic profile reflects a documented research presence in the molecular and pharmaceutical research context. Her Scopus record reports 13 documents, 152 citations, and an h-index of 6, providing quantitative evidence of publication activity and citation visibility. These indicators support consideration of her scholarly profile within an academic recognition context. [4]

References

  1. Elsevier. (n.d.). Scopus author details: Riham Bokhtia, Author ID 57209660751. Scopus.
    https://www.scopus.com/pages/authors/57209660751
  2. ORCID. (n.d.). ORCID record for Riham Bokhtia.
    https://orcid.org/0000-0001-5326-7364
  3. International Research Chemistry Awards. (n.d.).
    https://researchchemistry.org
  4. Bokhtia, R. M., et al. (n.d.). Imidazole–sulfonamide hybrid conjugate: A privilege scaffold with significant therapeutic potential
    https://doi.org/10.1016/j.ejmcr.2025.100321

Prof. xiangwen peng – Proteomics – Best Researcher Award

Prof. xiangwen peng – Proteomics – Best Researcher Award

Changsha Maternal and Child Health Hospital affiliated to Hunan Normal University, China

Author Profile

orcid

🎓 Academic Background

Prof. Xiangwen Peng pursued his Ph.D. in Heart Regeneration at Fudan University, Shanghai, China (2011-2016), where he conducted groundbreaking research on heart regeneration under the mentorship of Dr. Tao P. Zhong. Prior to this, he obtained his Master’s degree from Hunan Normal University, Changsha, China (2006-2009), focusing on Drosophila heart development under the guidance of Dr. Xiushan Wu and Dr. Rolf Bodmer. His academic journey began with a Bachelor’s degree in Aquaculture from Guangdong Ocean University, Guangdong, China (2001-2005), laying the foundation for his expertise in biological sciences.

🏥 Leadership in Hospital Research Development

Since October 2021, Prof. Xiangwen Peng has been serving as the Central Laboratory Director at Changsha Maternal and Child Health Hospital, affiliated with Hunan Normal University. His primary responsibility is the establishment and development of the hospital’s basic research center, which integrates both clinical and fundamental research to enhance medical advancements. Under his leadership, a multidisciplinary research platform has been created, covering zebrafish and mouse experimental models, cell biology, and molecular biology studies.

🧬 Postdoctoral and International Research Experience

Prof. Peng’s research career has been enriched by several postdoctoral and visiting scholar positions at prestigious institutions worldwide. He worked as a Postdoctoral Researcher at the Institute of Pediatrics, Guangzhou Women and Children’s Medical Centre, Guangzhou Medical University (2016-Present), where he focused on the role of noncanonical Wnt signaling in zebrafish heart regeneration. Between 2019 and 2020, he conducted postdoctoral research at the Medical College of Wisconsin, deepening his expertise in cardiac research. Prior to that, he worked as a Visiting Scholar at the McAllister Heart Institute, University of North Carolina at Chapel Hill (2018-2019), where he explored immune cell involvement in zebrafish heart regeneration, specifically T cell immunity, and gained valuable experience in single-cell research techniques.

🚀 Vision for Future Scientific Growth

Prof. Xiangwen Peng is dedicated to advancing medical research in maternal and child health. His evidence-based approach to hospital development is already yielding remarkable results, reinforcing his commitment to building a research-oriented hospital that integrates scientific innovation, clinical excellence, and academic leadership. Through his continuous efforts, he is paving the way for future medical breakthroughs and improved patient care.

Notable Publications📝


📝Identification of CSPG4 as a Biomarker and Therapeutic Target for Infantile Post‐Hemorrhagic Hydrocephalus via Multi‐Omics Analysis

Authors: Juncao Chen, Lin Wang, Xiangwen Peng, Tingting Cheng, Yihui Yang, Jingzhen Su, Hongmei Zou, Siyao Wang, Yueting Mao, Lixiang Wu, et al.

Journal: Advanced Science

Year: 2025


📝A patient with 18p11.32-p11.21 deletion have monaural deafness caused by an inadequate haplodose of THOC1: A case report

Authors: Geng Ouyang, Enhuan Yi, Huali Qin, Xingxing Duan, Sifeng Wang, Xiangwen Peng

Journal: Medicine

Year: 2024


📝Case Report: Wiedemann-Steiner syndrome with a new frameshift mutation in KMT2A

Authors: Jun He, Aimin Deng, Ying Chen, Shuyuan Yan, Yanling Wang, Tuanmei Wang, Xiangwen Peng

Journal: Preprint

Year: 2024


📝The clinical spectrum of a nonsense mutation in KAT6A: a case report

Authors: Dongbo Wang, Jun He, Xueyi Li, Shuyuan Yan, Linglin Pan, Tuanmei Wang, Liangrong Zhou, Jiyang Liu, Xiangwen Peng

Journal: Journal of International Medical Research

Year: 2022


📝Neomodified Koyanagi technique for severe hypospadias with one‐stage sealed Y‐shaped penis foreskin vascular protection surgery

Authors: Jiancheng Zu, Yifu Chen, Yu Liu, Tianqu He, Yanling Wang, Yuee Zu, Xiangwen Peng

Journal: Clinical Case Reports

Year: 2022